Clinical efficacy of mogamulizumab for relapsed/refractory aggressive adult T-cell leukemia/lymphoma: A retrospective analysis.

Atsushi SatakeAkiko KonishiYoshiko AzumaYukie TsubokuraHideaki YoshimuraMasaaki HottaTakahisa NakanishiShinya FujitaAya NakayaTomoki ItoKazuyoshi IshiiShosaku Nomura

Published in: European journal of haematology (2020)

In clinical practice, mogamulizumab improved OS in patients with relapsed/refractory ATL, especially those with acute-type ATL and skin rash.

Keyphrases

acute myeloid leukemia
diffuse large b cell lymphoma
acute lymphoblastic leukemia
clinical practice
multiple myeloma
hodgkin lymphoma
liver failure
respiratory failure
bone marrow
soft tissue
drug induced
wound healing
young adults
hepatitis b virus
childhood cancer
mechanical ventilation